Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1136/rmdopen-2022-002559
Copy DOI Journal: RMD Open |  Publication Date: Jan 1, 2023 |
 Citations: 5 |  License type: open-access |
Affiliation: Jiujiang First People's Hospital, Jiangxi Pingxiang People's Hospital, First Affiliated Hospital of Zhengzhou University, Zhuzhou Central Hospital, Pfizer (China), Pfizer (United States), Huashan Hospital, Fudan University, Peking University, Peking University First Hospital, Harbin Medical University, First Affiliated Hospital of Harbin Medical University, Jilin University, First Hospital of Jilin University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, West China Hospital of Sichuan University, Sichuan University, Jiangsu Province Hospital, Pfizer (Canada), First Affiliated Hospital of Kunming Medical University, Kunming Medical UniversityObjectivesEfficacy and safety of tofacitinib, an oral Janus kinase inhibitor, were evaluated in a 6-month, double-blind, phase 3 study in Chinese patients with active (polyarthritic) psoriatic arthritis (PsA) and inadequate...
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
